1. CCL11 (eotaxin‐1): A new diagnostic serum marker for prostate cancer. Issue 6 (11th October 2012) Authors: Agarwal, Manisha; He, Chang; Siddiqui, Javed; Wei, John T.; Macoska, Jill A. Journal: Prostate Issue: Volume 73:Issue 6(2013) Page Start: 573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inhibition of the CXCL12/CXCR4 axis prevents periurethral collagen accumulation and lower urinary tract dysfunction in vivo. Issue 7 (27th February 2019) Authors: Macoska, Jill A.; Wang, Zunyi; Virta, Johanna; Zacharias, Nicholas; Bjorling, Dale E. Journal: Prostate Issue: Volume 79:Issue 7(2019) Page Start: 757 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Obesity‐induced diabetes and lower urinary tract fibrosis promote urinary voiding dysfunction in a mouse model. Issue 10 (26th March 2013) Authors: Gharaee‐Kermani, Mehrnaz; Rodriguez‐Nieves, Jose A.; Mehra, Rohit; Vezina, Chad A.; Sarma, Aruna V.; Macoska, Jill A. Journal: Prostate Issue: Volume 73:Issue 10(2013) Page Start: 1123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗